Lilly Novo Nordisk Battle Intensifies as Obesity Drugs Surge
Eli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Volatility-adjusted returns show how total market funds stack up against SP 500 over time, highlighting stability versus peak swings for retirement savings.
28,240 articlesEli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
A major software conglomerate trading at a low forward multiple reports a record quarter, driving renewed investor in...
The FHFA proposes an outcome-based Duty to Serve overhaul to push Fannie Mae and Freddie Mac toward stronger support ...
MTUM has surged on momentum bets early in July, but a rotation out of high-multiple growth could weigh on the fund. T...
Jim Cramer says he cringes at owning AT&T or Verizon as Bernstein flags Starlink competition risk, signaling a potent...
In his first congressional testimony, chief Warsh pledged to clamp down on inflation with a data-driven approach and ...
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Ford reveals a heavy Q4 loss tied to Model e impairments, renewing Reddit-driven skepticism about its EV turnaround a...
Major banks reduced their Figma price targets even as the company posted rapid revenue growth, signaling that AI comp...
March data from the Case-Shiller indices confirms a slower pace of home price growth, signaling ongoing cooling acros...
A sweeping move by Spanish regulators targets prediction markets and the platforms that host them. This article expla...
Investors have seen Broadcom swing from a rough start to a strong rally. This guide breaks down whether today is the ...